Dr. Jed Kaminetsky, M.D, Medical Director
Michael Yang, CRC
Manhattan Medical Research
215 Lexington Avenue 21st Floor
New York, NY 10016
Manhattan Medical Research (MMR) is a multi-specialty medical research site proficient in Phase II-IV clinical trials. This new site expanded from University Urology Associates, which focuses mostly on urological studies. MMR will continue the tradition of UUA and expand the scope of research to target a wide range of therapeutic areas.
We are located in New York City, the largest city in the United States with a population well over 8 million residents. Due to our prime location, this exposes us to a wide variety of patient demographics, allowing for compliance with FDA standards for ethnically and racially diverse subject expectations. We are centrally located in Midtown Manhattan and in close proximity to public transportation allowing for easy access for our subjects.
We also have an extensive network in which we have the ability to partner with many other private practice physicians to augment recruitment of subjects. Additionally, we have a robust outreach program to further assist with recruitment of subjects. Our extensive industry experience enables us to offer our sponsors a quality research site with a trained and experienced clinical research team.
We have experience in Clinical Research Trials involving the following therapeutic areas:
We have earned the trust of pharmaceutical organizations, including:
Manhattan Medical Research is a state-of-the-art clinical research facility located in Midtown Manhattan. Our equipment and capabilities include:
Dr. Jed Kaminetsky, M.D. is a Medical Director at Manhattan Medical Research, a Clinical Associate Professor at New York University Medical Center, Associate medical Director of Gramercy Surgical Centre, and is a practicing urologist with University Urology Associates, one of the largest urologic practices in the New York City metropolitan area. He is a board-certified urologist and is highly skilled in treating all urologic disorders, performing minimally invasive prostate surgeries and penile implants. Dr. Kaminetsky's academic interests include the study of both male and female sexual dysfunction, which has led him to become a national and world thought leader.
Dr. Kaminetsky's work has been published in several journals which led to a nationwide recognition and development of various treatment schemes for patients with sexual, erectile dysfunction and androgen deficiency. Moreover, Dr. Kaminetsky is an experienced principal investigator who participates in national research studies that explore pharmacologic and diagnostic techniques for various urologic disorders. He is currently conducting studies addressing premature ejaculation, ED, male and female sexual dysfunction, BPH, prostate cancer, bladder cancer, voiding dysfunction, and hypogonadism. His hospital appointments include New York University Medical Center, New York Downtown Medical Center. Dr. Kaminetsky has been consulting for several pharmaceutical companies including Slate, Pfizer, Auxilium, Lilly, GlaxoSmithKline and American Medical Systems.
Dr. Edward Greaney. M.D. is a Principal Investigator at Manhattan Medical Research, a Clinical Assistant Professor at New York University Medical Center, and is a practicing internist with Murray Hill Medical Group. Dr. Greaney's medical interests include general internal medicine, pain management, heart disease, hypertension, sports medicine, and nutrition.
Dr. Virgil Hatcher. M.D. is a Principal Investigator at Manhattan Medical Research, a Clinical Assistant Professor at New York University Medical Center, and is a practicing dermatologist with Chelsea Dermatology. His medical expertise include pediatric dermatology, psoriasis, African American skin diseases, hair diseases, Botox injections, general dermatology, phototherapy.
Dr. Susan Zweig, M.D. is a Principle Investigator at Manhattan Medical Research, a Clinical Associate Professor at New York University School of Medicine, and a practicing Endocrinologist. As a Principle Investigator at Manhattan Medical Research, she has conducted over 10 studies concerning Type 1 and Type 2 Diabetes as well as weight loss.
Dr. Maria Betancourt, M.D. is a Principle Investigator at Manhattan Medical Research, a Clinical Assistant Professor at New York University, and a practicing Gynecologist. She is board certified in Obstetrics and Gynecology, and her clinical trial experience at Manhattan Medical Research extends across the Women’s Healthcare field, particularly in Uterine Fibroids.
UROLOGY: Jed Kaminetsky, M.D.
GASTROENTEROLOGY: Ian Lustbader, M.D., Daniel Alpert, M.D.
ORTHOPEDICS: Louis Re, M.D.
ENDOCRINOLOGY: Susan Zweig, M.D.
PULMONOLOGY: Wilfredo Talavera, M.D.
GYNECOLOGY: Maria Betancourt, M.D.
RHEUMATOLOGY: Marc Eberle, M.D.
ALLERGY: Clifford Basset, M.D.
Our location in Manhattan exposes us to a wide variety of patient demographics. New York City is the largest city in the United States with a population of more than 8 million people. This allows for compliance with FDA standards for ethnically and racially diverse subject expectations. We are centrally located and in close proximity to public transportation allowing for easy access for our subjects and sponsors visits. We are centrally located and in close proximity to public transportation allowing for easy access for our subjects and sponsors visits. The following are techniques we implement to recruit and make our community aware of our various clinical trials.
Manhattan Medical Research utilizes a Central IRB. Regulatory documents are completed within 5 days, allowing for a quick turnaround. All case report data is entered shortly after subject visit has been completed. In addition, we frequently check all data systems on a daily basis, allowing for a fast turnaround of query resolution.